Fisher & Paykel boss Lewis Gradon gets hefty pay boost after hitting targets

Fisher & Paykel boss Lewis Gradon gets hefty pay boost after hitting targets
Fisher & Paykel Healthcare and its managing director Lewis Gradon hit targets for operating revenue, profit and cashflow. (Image: NZME)
Rebecca Stevenson
New Zealand Exchange-listed medical device manufacturer Fisher & Paykel Healthcare says the feedback from US customers on its new solo mask for obstructive sleep apnea has been tremendous. Fisher & Paykel reported its full-year result to March 31 on Wednesday, reporting underlying net profit after tax of $264.4 million after stripping out one-off items including a $98m revaluation of land it purchased at Karaka. Free cashflow rose to $73.8m compared to $12.5m in the previous financial year, while operating revenue wa...

More Markets

NZ sharemarket down following Warehouse downgrade
Markets Market close

NZ sharemarket down following Warehouse downgrade

The S&P/NZX 50 Index closed at 11,627.86, down 54.52 points or 0.47%

Graham Skellern 24 Jun 2024
Fletcher director Rob McDonald speeds up exit
Markets

Fletcher director Rob McDonald speeds up exit

Contact Energy chair and Vector chair will go out as they came in: together.

The Warehouse forecasts ebit to fall 64% in FY24
Retail

The Warehouse forecasts ebit to fall 64% in FY24

 Annual sales from continuing operations are expected to fall 6-7% on the year.

Staff reporters 24 Jun 2024
Mercury launches capital bond offer
Markets

Mercury launches capital bond offer

Mercury NZ is offering up to $300 million. 

Staff reporters 24 Jun 2024